These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 7747475

  • 1. Murine cytomegalovirus IE2, an activator of gene expression, is dispensable for growth and latency in mice.
    Cardin RD, Abenes GB, Stoddart CA, Mocarski ES.
    Virology; 1995 May 10; 209(1):236-41. PubMed ID: 7747475
    [Abstract] [Full Text] [Related]

  • 2. Reduced levels of IE2 gene expression and shutdown of early and late viral genes during latent infection of the glioblastoma cell line U138-MG with selectable recombinants of human cytomegalovirus.
    Wolff D, Sinzger C, Drescher P, Jahn G, Plachter B.
    Virology; 1994 Oct 10; 204(1):101-13. PubMed ID: 8091645
    [Abstract] [Full Text] [Related]

  • 3. Differential expression of the immediate-early 2 and 3 proteins in developing mouse brains infected with murine cytomegalovirus.
    Ishiwata M, Baba S, Kawashima M, Kosugi I, Kawasaki H, Kaneta M, Tsuchida T, Kozuma S, Tsutsui Y.
    Arch Virol; 2006 Nov 10; 151(11):2181-96. PubMed ID: 16755372
    [Abstract] [Full Text] [Related]

  • 4. Investigation of murine cytomegalovirus latency and reactivation in mice using viral mutants and the polymerase chain reaction.
    Bevan IS, Sammons CC, Sweet C.
    J Med Virol; 1996 Apr 10; 48(4):308-20. PubMed ID: 8699162
    [Abstract] [Full Text] [Related]

  • 5. Insertional mutagenesis of the murine cytomegalovirus genome: one prominent alpha gene (ie2) is dispensable for growth.
    Manning WC, Mocarski ES.
    Virology; 1988 Dec 10; 167(2):477-84. PubMed ID: 2849236
    [Abstract] [Full Text] [Related]

  • 6. Random, asynchronous, and asymmetric transcriptional activity of enhancer-flanking major immediate-early genes ie1/3 and ie2 during murine cytomegalovirus latency in the lungs.
    Grzimek NK, Dreis D, Schmalz S, Reddehase MJ.
    J Virol; 2001 Mar 10; 75(6):2692-705. PubMed ID: 11222693
    [Abstract] [Full Text] [Related]

  • 7. Identification of human cytomegalovirus target sequences in the human immunodeficiency virus long terminal repeat. Potential role of IE2-86 binding to sequences between -120 and -20 in promoter transactivation.
    Yurochko AD, Huong SM, Huang ES.
    J Hum Virol; 1999 Mar 10; 2(2):81-90. PubMed ID: 10225210
    [Abstract] [Full Text] [Related]

  • 8. The human cytomegalovirus IE2 86 kDa protein elevates p53 levels and transactivates the p53 promoter in human fibroblasts.
    Muganda P, Carrasco R, Qian Q.
    Cell Mol Biol (Noisy-le-grand); 1998 Mar 10; 44(2):321-31. PubMed ID: 9593583
    [Abstract] [Full Text] [Related]

  • 9. Mutations of the human cytomegalovirus immediate-early 2 protein defines regions and amino acid motifs important in transactivation of transcription from the HIV-1 LTR promoter.
    Yeung KC, Stoltzfus CM, Stinski MF.
    Virology; 1993 Aug 10; 195(2):786-92. PubMed ID: 8337845
    [Abstract] [Full Text] [Related]

  • 10. Mutagenesis of murine cytomegalovirus using a Tn3-based transposon.
    Zhan X, Lee M, Abenes G, Von Reis I, Kittinunvorakoon C, Ross-Macdonald P, Snyder M, Liu F.
    Virology; 2000 Jan 20; 266(2):264-74. PubMed ID: 10639313
    [Abstract] [Full Text] [Related]

  • 11. Human cytomegalovirus late protein encoded by ie2: a trans-activator as well as a repressor of gene expression.
    Jenkins DE, Martens CL, Mocarski ES.
    J Gen Virol; 1994 Sep 20; 75 ( Pt 9)():2337-48. PubMed ID: 8077932
    [Abstract] [Full Text] [Related]

  • 12. Murine cytomegalovirus major immediate-early enhancer region operating as a genetic switch in bidirectional gene pair transcription.
    Simon CO, Kühnapfel B, Reddehase MJ, Grzimek NK.
    J Virol; 2007 Jul 20; 81(14):7805-10. PubMed ID: 17494084
    [Abstract] [Full Text] [Related]

  • 13. Negative regulation of a heterologous promoter by human cytomegalovirus immediate-early protein IE2.
    Tsai HL, Kou GH, Tang FM, Wu CW, Lin YS.
    Virology; 1997 Nov 24; 238(2):372-9. PubMed ID: 9400610
    [Abstract] [Full Text] [Related]

  • 14. NF-kappaB--a potential therapeutic target for inhibition of human cytomegalovirus (re)activation?
    Prösch S, Wuttke R, Krüger DH, Volk HD.
    Biol Chem; 2002 Oct 24; 383(10):1601-9. PubMed ID: 12452437
    [Abstract] [Full Text] [Related]

  • 15. Human cytomegalovirus US3 gene expression is regulated by a complex network of positive and negative regulators.
    Biegalke BJ.
    Virology; 1999 Sep 01; 261(2):155-64. PubMed ID: 10497101
    [Abstract] [Full Text] [Related]

  • 16. The immediate early gene 1 product of human cytomegalovirus is sufficient for up-regulation of interleukin-8 gene expression.
    Murayama T, Mukaida N, Sadanari H, Yamaguchi N, Khabar KS, Tanaka J, Matsushima K, Mori S, Eizuru Y.
    Biochem Biophys Res Commun; 2000 Dec 09; 279(1):298-304. PubMed ID: 11112456
    [Abstract] [Full Text] [Related]

  • 17. Role for tumor necrosis factor alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs.
    Simon CO, Seckert CK, Dreis D, Reddehase MJ, Grzimek NK.
    J Virol; 2005 Jan 09; 79(1):326-40. PubMed ID: 15596827
    [Abstract] [Full Text] [Related]

  • 18. Murine cytomegalovirus gene amplification and culture after submaxillary salivary gland biopsy.
    Schmader KE, Rahija RJ, Porter KR, Hamilton JD.
    Lab Anim Sci; 1991 Oct 09; 41(5):396-400. PubMed ID: 1666135
    [Abstract] [Full Text] [Related]

  • 19. The IE2 60-kilodalton and 40-kilodalton proteins are dispensable for human cytomegalovirus replication but are required for efficient delayed early and late gene expression and production of infectious virus.
    White EA, Del Rosario CJ, Sanders RL, Spector DH.
    J Virol; 2007 Mar 09; 81(6):2573-83. PubMed ID: 17202222
    [Abstract] [Full Text] [Related]

  • 20. Structural organization, expression, and functional characterization of the murine cytomegalovirus immediate-early gene 3.
    Messerle M, Bühler B, Keil GM, Koszinowski UH.
    J Virol; 1992 Jan 09; 66(1):27-36. PubMed ID: 1309246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.